Impact of COVID-19 on Cardiovascular Disease
Viruses · 11.02.2023 · 15 (2) · 508
DOI: 10.3390/v15020508 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Viruses, online erschienen am 11.02.2023. Verfasst von Ivan Vosko und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Medical University of Graz, 8036 Graz, Austria. Hauptthemen laut MEDLINE: Cardiovascular Diseases, COVID-19, Heart Failure. Die Arbeit wurde bisher 114-mal zitiert (Crossref) und nennt 243 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Austrian Cardiologic Society, Austrian Science Fund, Austrian Diabetes Association.
Abstract (Originalsprache)
Coronavirus disease 2019 (COVID-19) is a viral infection with the novel severe acute respiratory distress syndrome corona virus 2 (SARS-CoV-2). Until now, more than 670 million people have suffered from COVID-19 worldwide, and roughly 7 million death cases were attributed to COVID-19. Recent evidence suggests an interplay between COVID-19 and cardiovascular disease (CVD). COVID-19 may serve as a yet underappreciated CVD risk modifier, including risk factors such as diabetes mellitus or arterial hypertension. In addition, recent data suggest that previous COVID-19 may increase the risk for many entities of CVD to an extent similarly observed for traditional cardiovascular (CV) risk factors. Furthermore, increased CVD incidence and worse clinical outcomes in individuals with preexisting CVD have been observed for myocarditis, acute coronary syndrome, heart failure (HF), thromboembolic complications, and arrhythmias. Direct and indirect mechanisms have been proposed by which COVID-19 may impact CVD and CV risk, including viral entry into CV tissue or by the induction of a massive systemic inflammatory response. In the current review, we provide an overview of the literature reporting an interaction between COVID-19 and CVD, review potential mechanisms underlying this interaction, and discuss preventive and treatment strategies and their interference with CVD that were evaluated since the onset of the COVID-19 pandemic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Medical University of Graz, 8036 Graz, Austria.
ORCID-Profile: Ivan Vosko
Förderung
- Austrian Cardiologic Society
- Austrian Science Fund
- Austrian Diabetes Association
Zitieren
APA
Vosko, I., Zirlik, A., & Bugger, H. (2023). Impact of COVID-19 on Cardiovascular Disease. Viruses, 15(2), 508. https://doi.org/10.3390/v15020508
Vancouver
Vosko I, Zirlik A, Bugger H. Impact of COVID-19 on Cardiovascular Disease. Viruses. 2023;15(2):508. doi:10.3390/v15020508
BibTeX
@article{Vosko2023,
author = {Vosko, Ivan and Zirlik, Andreas and Bugger, Heiko},
title = {Impact of COVID-19 on Cardiovascular Disease},
journal = {Viruses},
year = {2023},
volume = {15},
number = {2},
pages = {508},
doi = {10.3390/v15020508}
}
EUVIMED